A carregar...
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate
Liver X receptor (LXR) agonists have been explored as potential treatments for atherosclerosis and other diseases based on their ability to induce reverse cholesterol transport and suppress inflammation. However, this therapeutic potential has been hindered by on-target adverse effects in the liver...
Na minha lista:
| Publicado no: | Bioconjug Chem |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4651790/ https://ncbi.nlm.nih.gov/pubmed/25945727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.bioconjchem.5b00203 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|